Willingness to participate in clinical trials and expectations towards antiretroviral therapy among heavily treatment‐experienced people living with HIV : A feasibility survey
HIV Medicine · 2025
DOI: 10.1111/hiv.70053 ↗Kurz gefasst
Fachartikel in der Zeitschrift HIV Medicine, 2025. Verfasst von Marie Ballif und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: HIV Infections, Anti-HIV Agents, Clinical Trials as Topic, Anti-Retroviral Agents. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Wellcome Trust, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Swiss HIV Cohort Research Foundation.
Abstract (Originalsprache)
Introduction
As life expectancy among persons with HIV on antiretroviral therapy (ART) is increasing, comorbidities and polypharmacy increase. Drug–drug interactions (DDIs) are common among persons with HIV with a history of virological failure, since many are receiving boosted ART. We assessed the willingness of individuals with a history of virological failure on a boosted ART to participate in simplification trials and evaluated their expectations towards ART.
Methods
We conducted a cross‐sectional survey among persons with HIV at five hospitals in Switzerland between October 2021 and July 2022. We collected data using quantitative paper‐based questionnaires and analysed the data using descriptive statistics. Community representatives were involved in the study planning and conduct, and in the interpretation of findings.
Results
Overall, 143 (64%) of 223 eligible persons with HIV participated. Median age was 59 years (interquartile range [IQR] 52.5–63.5), 32 (22%) were female, median time on ART was 26 years (IQR: 20–27). Among participants, 104 (72%) would agree to participate in clinical trials aiming at evaluating simplified ART regimens with reduced DDI risks, or were still undecided. Of them, 92 (88%) were satisfied with their current treatment. Their main expectations about simplified ART were treatment efficacy (91%), fewer DDIs (83%), low pill number (78%) and forgiveness in case of missed doses (75%).
Conclusions
Persons with HIV and a history of virological failure were motivated to participate in clinical research. This underlines the importance of including them in future trials. Furthermore, conducting feasibility surveys and including persons with HIV in the study design prior to trials ensures their relevance and alignment with people's needs and expectations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
- Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
- Positive Council, Zurich, Switzerland.
- Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, Switzerland.
- Division of Infectious Diseases, Cantonal Hospital of St Gallen, St Gallen, Switzerland.
- Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
ORCID-Profile: Marie Ballif
Förderung
- Wellcome Trust
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Swiss HIV Cohort Research Foundation
Zitieren
APA
Ballif, M., Correia da Silva Saúde, M., Haerry, D., Stoeckle, M., Schmid, P., Braun, D., Calmy, A., Wandeler, G., & Surial, B. (2025). Willingness to participate in clinical trials and expectations towards antiretroviral therapy among heavily treatment‐experienced people living with HIV : A feasibility survey. HIV Medicine. https://doi.org/10.1111/hiv.70053
Vancouver
Ballif M, Correia da Silva Saúde M, Haerry D, Stoeckle M, Schmid P, Braun D, et al. Willingness to participate in clinical trials and expectations towards antiretroviral therapy among heavily treatment‐experienced people living with HIV : A feasibility survey. HIV Medicine. 2025. doi:10.1111/hiv.70053
BibTeX
@article{Ballif2025,
author = {Ballif, Marie and Correia da Silva Saúde, Manuela and Haerry, David and Stoeckle, Marcel and Schmid, Patrick and Braun, Dominique and Calmy, Alexandra and Wandeler, Gilles and Surial, Bernard},
title = {Willingness to participate in clinical trials and expectations towards antiretroviral therapy among heavily treatment‐experienced people living with HIV : A feasibility survey},
journal = {HIV Medicine},
year = {2025},
doi = {10.1111/hiv.70053}
}
EUVIMED